285926
Translating chw asthma interventions from research to sustainability (please note, this presentation is envisioned as an entire oral session with four presenters)
Seattle King County Health Department presents its research on the intervention's effectiveness when focused on high risk children. The presenter will review the subsequent research confirming that this model can improve health outcomes and reduce costs by approximately 20%. Seattle King County will describe their efforts to sustain this intervention by partnering with publicly-funded insurers.
Boston Medical Center, Baystate Medical Center, and Boston Public Health Commission present their translation of the Seattle King County model to real world implementation at hospitals that serve the largest number of low income families in the state and at a local health department that serves a population most at risk for poor health outcomes in the state. Different approaches to integrating this model into the medical and public health systems will be explored.
The Massachusetts Department of Public Health (MDPH) describes their efforts and that of their partners to sustain this intervention through insurance coverage and local capacity building. MDPH will discuss their partnership with Medicaid and managed care Medicaid, their development of a CHW training program, and their evaluation of state infrastructure needed to support wide-spread implementation of this model.
Learning Areas:
Chronic disease management and preventionClinical medicine applied in public health
Public health or related public policy
Learning Objectives:
Identify the various stages of translating research into a sustainable intervention
Keyword(s): Asthma, Health Care Reform
Qualified on the content I am responsible for because: I am a PI on the READY study research project and run the Asthma Prevention and Control Program at the MDPH.
Any relevant financial relationships? No
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.